Revolution Medicines, Inc. (RVMD) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -354.17M | -274.24M | -207.31M | -221.76M | -194.44M | -138.29M | -130.42M | -128.17M | -160.56M | -120.56M | -100.5M | -67.12M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | -16248.38% | - | -1755.26% |
| Operating CF Growth % | -82.15% | -98.31% | -58.96% | -73.02% | -21.1% | -14.7% | -29.77% | -90.95% | -157.34% | -95.12% | -94.25% | -20.47% |
| Net Income | -453.82M | -364.89M | -305.21M | -247.79M | -213.42M | -194.57M | -156.29M | -133.23M | -116M | -161.54M | -108.43M | -98.3M |
| Depreciation & Amortization | 4.54M | 33.33M | 4.34M | 3.8M | 3.72M | 3.39M | 66K | 2.8M | 2.76M | 2.86M | 2.15M | 1.77M |
| Stock-Based Compensation | 0 | 33.7M | 30.78M | 28.83M | 25.08M | 22.44M | 20.77M | 19.77M | 16.21M | 25.43M | 13.67M | 12.98M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | -762K | 0 | 0 | 0 | -43K | -3.87M | 0 |
| Other Non-Cash Items | 112.06M | -8.61M | 6.33M | -2.3M | -12.26M | -11.57M | -8.1M | -12.77M | -16.32M | -8.47M | -5.14M | -4.85M |
| Working Capital Changes | -16.95M | 32.25M | 56.44M | -4.3M | 2.44M | 42.78M | 13.13M | -4.74M | -47.21M | 21.2M | 1.14M | 21.27M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.25M | -945K | 2.2M | 1.49M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.59M |
| Change in Payables | 16.86M | -10.5M | 19.55M | 8.76M | -8.27M | 29.36M | -2.79M | -4.08M | -28.96M | 24.3M | 580K | 8.63M |
| Cash from Investing | 172.62M | 74.88M | 24.85M | 34.28M | -15.95M | -392.9M | -21.47M | 107.94M | -247.97M | -380.4M | 77.35M | -43.54M |
| Capital Expenditures | -1.54M | -1.93M | -3.35M | -7.45M | -3.27M | -1.22M | -3.52M | -2.4M | -3.17M | -2.32M | -2.54M | -1.12M |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | 312.26% | - | 29.26% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42.42M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -42.42M |
| Cash from Financing | 238.74M | 365.66M | -1.59M | 256.58M | 874K | 873.8M | 77.29M | 7.5M | 810K | 839.35M | 1.01M | 64.63M |
| Debt Issued (Net) | 0 | 244.22M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 238.74M | 365.47M | 4.15M | 6.58M | 892K | 873.52M | 74.29M | 7.5M | 810K | 2.55M | 1.01M | 62.05M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -244.02M | -5.74M | 250M | -18K | 284K | 3M | 0 | 0 | 836.81M | 0 | 2.58M |
| Net Change in Cash | 57.19M | 166.3M | -184.05M | 69.1M | -209.51M | 341.8M | -74.59M | -12.72M | -407.72M | 337.75M | -21.93M | -46.03M |
| Free Cash Flow | -355.7M | -276.16M | -210.66M | -229.21M | -197.7M | -139.51M | -133.94M | -130.57M | -163.73M | -122.88M | -103.03M | -68.24M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | -16560.65% | - | -1784.52% |
| FCF Growth % | -79.92% | -97.95% | -57.28% | -75.55% | -20.75% | -13.54% | -30% | -91.33% | -155.23% | -90.03% | -86.44% | -17.17% |
| FCF per Share | -1.80 | -1.45 | -1.11 | -1.22 | -1.05 | -0.83 | -0.80 | -0.79 | -0.99 | -0.87 | -0.94 | -0.64 |
| FCF Conversion (FCF/Net Income) | 0.78x | 0.75x | 0.68x | 0.89x | 0.91x | 0.71x | 0.83x | 0.96x | 1.38x | 0.75x | 0.93x | 0.68x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |